$807.71
Price
$83.2B
Market Cap
20.2
P/E Ratio
13.3
Forward P/E
$40.06
EPS (TTM)
0.46%
Dividend Yield
$8.0B
Cash
$2.7B
Total Debt
101M
Shares Out
$541.00
$847.00
52-Week Range
Institutional Ownership of Regeneron Pharmaceuticals
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 152.3K | $95M | $662.99 | +21.83% | ||
| 127.0K | $79M | $608.36 | +32.77% |
Trading Activity for Regeneron Pharmaceuticals
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q2 | |||||
| SELL | -15.9% | 127.0K | $79M | $698.25 | |
| BUY | +16.6% | 152.3K | $95M | $698.25 | |
| 2026-Q1 | |||||
| SELL | -14.2% | 151.0K | $117M | $764.08 | |
| SELL | -21.2% | 130.7K | $101M | $764.08 | |
| 2025-Q4 | |||||
| BUY | +52.9% | 175.9K | $136M | $692.58 | |
| BUY | +14.7% | 165.8K | $128M | $692.58 | |
| 2025-Q3 | |||||
| SELL | -9.9% | 144.6K | $81M | $563.80 | |
| BUY | NEW | 115.0K | $65M | $563.80 | |
| 2025-Q2 | |||||
| BUY | +39.8% | 160.6K | $84M | $563.16 | |
| 2025-Q1 | |||||
| BUY | NEW | 114.9K | $73M | $687.27 | |
Insider Trading for Regeneron Pharmaceuticals
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.